MedTrace Logo

Regular Diet Versus Extended Low Residue After Colon Surgery

NCT07083076 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2025-09-24

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a 10 day low-residue diet restriction is better for bowel function and quality of life without increasing complications compared to a 6 week low-residue diet restriction after elective colon resection surgery. The main questions it aims to answer are:

Does a shorter time period of low residue restriction result in a faster return to normal bowel function? Are there any differences in complication rate between a 10 day low-residue diet restriction compared to a 6 week low-residue diet restriction?

Participants will be randomized to one of the two diet plans and will be asked to answer surveys about their bowel function and health care related quality of life at various time points for up to 3 months.

Conditions

  • Colon Resection

Interventions

OTHER

Short term (10 day) low residue diet restriction

Patients will have an unrestricted diet (as opposed to a low residue diet restriction) 10 days after surgery.

OTHER

6 week low residue diet restriction

Patients will be restricted to a low residue diet for 6 weeks after surgery. After this period, their diet will be unrestricted.

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Andrea Zimmern, MD · Northwell Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-19
Primary Completion
2026-07-01
Completion
2028-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07083076 on ClinicalTrials.gov